NPPB and hydrops fetalis: NT-proBNP, a marker of myocardial stretch and neurohormonal activation, is the only biomarker that is currently included in HF guidelines [34] and it has shown incremental diagnostic and prognostic value in HFrEF and HFpEF [35, 36].